Can lumacaftor-ivacaftor reverse glucose-tolerance abnormalities in cystic fibrosis?

Affiliations

Free article

Comment

Laurence Kessler. J Cyst Fibros. 2020 Jul.

Free article

. 2020 Jul;19(4):666.

doi: 10.1016/j.jcf.2020.04.013. Epub 2020 May 5.

¹ Department of Diabetology, University Hospital of Strasbourg, France. Electronic address: laurence.kessler@chru-strasbourg.fr.

No abstract available

Comment on

Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients.
Misgault B, Chatron E, Reynaud Q, Touzet S, Abely M, Melly L, Dominique S, Troussier F, Ronsin-Pradel O, Gerardin M, Mankikian J, Cosson L, Chiron R, Bounyar L, Porzio M, Durieu I, Weiss L, Kessler R, Kessler L. Misgault B, et al. J Cyst Fibros. 2020 Sep;19(5):712-716. doi: 10.1016/j.jcf.2020.03.002. Epub 2020 Mar 19. J Cyst Fibros. 2020. PMID: 32201160
Comment on "Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients".
Ballmann M, Prinz N, Glass A, Holl R. Ballmann M, et al. J Cyst Fibros. 2020 Sep;19(5):839. doi: 10.1016/j.jcf.2020.04.009. Epub 2020 Jun 2. J Cyst Fibros. 2020. PMID: 32507542 No abstract available.